147 related articles for article (PubMed ID: 10640590)
1. Evaluation of novel soya-lecithin formulations for dermal use containing ketoprofen as a model drug.
Valenta C; Wanka M; Heidlas J
J Control Release; 2000 Jan; 63(1-2):165-73. PubMed ID: 10640590
[TBL] [Abstract][Full Text] [Related]
2. Effect of various vehicles on ketoprofen permeation across artificial membranes and excised rat skin.
Valenta C; Kerner A
Pharmazie; 1996 Aug; 51(8):605-6. PubMed ID: 8794474
[No Abstract] [Full Text] [Related]
3. Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling.
Elkomy MH; Elmenshawe SF; Eid HM; Ali AM
Drug Deliv; 2016 Nov; 23(9):3294-3306. PubMed ID: 27066917
[TBL] [Abstract][Full Text] [Related]
4. Lecithin microemulsions for the topical administration of ketoprofen: percutaneous adsorption through human skin and in vivo human skin tolerability.
Paolino D; Ventura CA; Nisticò S; Puglisi G; Fresta M
Int J Pharm; 2002 Sep; 244(1-2):21-31. PubMed ID: 12204562
[TBL] [Abstract][Full Text] [Related]
5. Transdermal delivery of ketoprofen: the influence of drug-dioleylphosphatidylcholine interactions.
Garcia MT; da Silva CH; de Oliveira DC; Braga EC; Thomazini JA; Bentley MV
Pharm Res; 2006 Aug; 23(8):1776-85. PubMed ID: 16858649
[TBL] [Abstract][Full Text] [Related]
6. Correlation between the transdermal permeation of ketoprofen and its solubility in mixtures of a pH 6.5 phosphate buffer and various solvents.
Ceschel GC; Maffei P; Lombardi Borgia S
Drug Deliv; 2002; 9(1):39-45. PubMed ID: 11839207
[TBL] [Abstract][Full Text] [Related]
7. In vitro percutaneous absorption of ketoprofen and testosterone: comparison of pluronic lecithin organogel vs. pentravan cream.
Lehman PA; Raney SG
Int J Pharm Compd; 2012; 16(3):248-52. PubMed ID: 23050302
[TBL] [Abstract][Full Text] [Related]
8. Topical delivery of aceclofenac from lecithin organogels: preformulation study.
Shaikh IM; Jadhav KR; Gide PS; Kadam VJ; Pisal SS
Curr Drug Deliv; 2006 Oct; 3(4):417-27. PubMed ID: 17076644
[TBL] [Abstract][Full Text] [Related]
9. Effect of permeation enhancers on the release of ketoprofen through transdermal drug delivery systems.
Singh SK; Durrani MJ; Reddy IK; Khan MA
Pharmazie; 1996 Oct; 51(10):741-4. PubMed ID: 8941942
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and Antiinflammatory Effect of a Novel Gel System Containing Ketoprofen Solid Nanoparticles.
Nagai N; Iwamae A; Tanimoto S; Yoshioka C; Ito Y
Biol Pharm Bull; 2015; 38(12):1918-24. PubMed ID: 26632183
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel ketoprofen transdermal patch: effect of almond oil as penetration enhancers on in-vitro and ex-vivo penetration of ketoprofen through rabbit skin.
Hussain A; Khan GM; Shah SU; Shah KU; Rahim N; Wahab A; Rehman AU
Pak J Pharm Sci; 2012 Jan; 25(1):227-32. PubMed ID: 22186334
[TBL] [Abstract][Full Text] [Related]
12. Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations.
Cevc G; Mazgareanu S; Rother M; Vierl U
Int J Pharm; 2008 Jul; 359(1-2):190-7. PubMed ID: 18499370
[TBL] [Abstract][Full Text] [Related]
13. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
Singh S; Gajra B; Rawat M; Muthu MS
Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
[TBL] [Abstract][Full Text] [Related]
14. In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers.
Tas C; Ozkan Y; Okyar A; Savaser A
Drug Deliv; 2007 Oct; 14(7):453-9. PubMed ID: 17994363
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro evaluation of a pluronic lecithin organogel containing ricinoleic acid for transdermal delivery.
Boddu SH; Bonam SP; Wei Y; Alexander K
Int J Pharm Compd; 2014; 18(3):256-61. PubMed ID: 25306775
[TBL] [Abstract][Full Text] [Related]
16. In-vitro transcutaneous delivery of ketoprofen and polyunsaturated fatty acids from a pluronic lecithin organogel vehicle containing fish oil.
Richards H; Thomas CP; Bowen JL; Heard CM
J Pharm Pharmacol; 2006 Jul; 58(7):903-8. PubMed ID: 16805949
[TBL] [Abstract][Full Text] [Related]
17. The delivery of ketoprofen from a system containing ion-exchange fibers.
Yu L; Li S; Yuan Y; Dai Y; Liu H
Int J Pharm; 2006 Aug; 319(1-2):107-13. PubMed ID: 16701973
[TBL] [Abstract][Full Text] [Related]
18. Effect of microneedle on the pharmacokinetics of ketoprofen from its transdermal formulations.
So JW; Park HH; Lee SS; Kim DC; Shin SC; Cho CW
Drug Deliv; 2009 Jan; 16(1):52-6. PubMed ID: 19555309
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2005 Jul; 298(1):55-67. PubMed ID: 15941634
[TBL] [Abstract][Full Text] [Related]
20. Cremophor RH40-PEG 400 microemulsions as transdermal drug delivery carrier for ketoprofen.
Ngawhirunpat T; Worachun N; Opanasopit P; Rojanarata T; Panomsuk S
Pharm Dev Technol; 2013; 18(4):798-803. PubMed ID: 22023398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
